Literature DB >> 22314537

Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing.

Tim Holm Jakobsen1, Maria van Gennip, Richard Kerry Phipps, Meenakshi Sundaram Shanmugham, Louise Dahl Christensen, Morten Alhede, Mette Eline Skindersoe, Thomas Bovbjerg Rasmussen, Karlheinz Friedrich, Friedrich Uthe, Peter Østrup Jensen, Claus Moser, Kristian Fog Nielsen, Leo Eberl, Thomas Ostenfeld Larsen, David Tanner, Niels Høiby, Thomas Bjarnsholt, Michael Givskov.   

Abstract

In relation to emerging multiresistant bacteria, development of antimicrobials and new treatment strategies of infections should be expected to become a high-priority research area. Quorum sensing (QS), a communication system used by pathogenic bacteria like Pseudomonas aeruginosa to synchronize the expression of specific genes involved in pathogenicity, is a possible drug target. Previous in vitro and in vivo studies revealed a significant inhibition of P. aeruginosa QS by crude garlic extract. By bioassay-guided fractionation of garlic extracts, we determined the primary QS inhibitor present in garlic to be ajoene, a sulfur-containing compound with potential as an antipathogenic drug. By comprehensive in vitro and in vivo studies, the effect of synthetic ajoene toward P. aeruginosa was elucidated. DNA microarray studies of ajoene-treated P. aeruginosa cultures revealed a concentration-dependent attenuation of a few but central QS-controlled virulence factors, including rhamnolipid. Furthermore, ajoene treatment of in vitro biofilms demonstrated a clear synergistic, antimicrobial effect with tobramycin on biofilm killing and a cease in lytic necrosis of polymorphonuclear leukocytes. Furthermore, in a mouse model of pulmonary infection, a significant clearing of infecting P. aeruginosa was detected in ajoene-treated mice compared to a nontreated control group. This study adds to the list of examples demonstrating the potential of QS-interfering compounds in the treatment of bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22314537      PMCID: PMC3346669          DOI: 10.1128/AAC.05919-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  73 in total

1.  Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model.

Authors:  Louise D Christensen; Maria van Gennip; Tim H Jakobsen; Morten Alhede; Hans Petter Hougen; Niels Høiby; Thomas Bjarnsholt; Michael Givskov
Journal:  J Antimicrob Chemother       Date:  2012-02-01       Impact factor: 5.790

2.  Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo.

Authors:  Gilles Brackman; Paul Cos; Louis Maes; Hans J Nelis; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

Review 3.  Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators.

Authors:  W C Fuqua; S C Winans; E P Greenberg
Journal:  J Bacteriol       Date:  1994-01       Impact factor: 3.490

4.  Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-08

5.  A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa.

Authors:  J P Pearson; L Passador; B H Iglewski; E P Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice.

Authors:  H Wu; Z Song; M Hentzer; J B Andersen; S Molin; M Givskov; N Høiby
Journal:  J Antimicrob Chemother       Date:  2004-04-29       Impact factor: 5.790

7.  Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes.

Authors:  J P Pearson; K M Gray; L Passador; K D Tucker; A Eberhard; B H Iglewski; E P Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase.

Authors:  T Brandt; S Breitenstein; H von der Hardt; B Tümmler
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

9.  Effects of Pseudomonas aeruginosa rhamnolipids on human monocyte-derived macrophages.

Authors:  C D McClure; N L Schiller
Journal:  J Leukoc Biol       Date:  1992-02       Impact factor: 4.962

10.  Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.

Authors:  P M Mendelman; A L Smith; J Levy; A Weber; B Ramsey; R L Davis
Journal:  Am Rev Respir Dis       Date:  1985-10
View more
  97 in total

1.  Combined effects of Allium sativum and Cuminum cyminum essential oils on planktonic and biofilm forms of Salmonella typhimurium isolates.

Authors:  Reza Hakimi Alni; Khodayar Ghorban; Maryam Dadmanesh
Journal:  3 Biotech       Date:  2020-06-23       Impact factor: 2.406

Review 2.  Role of quorum sensing in bacterial infections.

Authors:  Israel Castillo-Juárez; Toshinari Maeda; Edna Ayerim Mandujano-Tinoco; María Tomás; Berenice Pérez-Eretza; Silvia Julieta García-Contreras; Thomas K Wood; Rodolfo García-Contreras
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

Review 3.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

4.  Natural products as inspiration for the development of bacterial antibiofilm agents.

Authors:  Roberta J Melander; Akash K Basak; Christian Melander
Journal:  Nat Prod Rep       Date:  2020-07-01       Impact factor: 13.423

Review 5.  Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs.

Authors:  Hiroshi Ogawara
Journal:  J Antibiot (Tokyo)       Date:  2020-07-09       Impact factor: 2.649

Review 6.  Control of Biofilm Formation: Antibiotics and Beyond.

Authors:  Ammar Algburi; Nicole Comito; Dimitri Kashtanov; Leon M T Dicks; Michael L Chikindas
Journal:  Appl Environ Microbiol       Date:  2017-01-17       Impact factor: 4.792

Review 7.  Exploiting quorum sensing to confuse bacterial pathogens.

Authors:  Breah LaSarre; Michael J Federle
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

Review 8.  Biofilms 2012: new discoveries and significant wrinkles in a dynamic field.

Authors:  Susanne Haussler; Clay Fuqua
Journal:  J Bacteriol       Date:  2013-04-26       Impact factor: 3.490

9.  New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing.

Authors:  Francesco Imperi; Francesco Massai; Cejoice Ramachandran Pillai; Francesca Longo; Elisabetta Zennaro; Giordano Rampioni; Paolo Visca; Livia Leoni
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

Review 10.  Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.

Authors:  Nicholas M Maurice; Brahmchetna Bedi; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.